Furthermore, a recent clinical study comparing the effect of neoadjuvant letrozole with that of letrozole plus metronomic cyclophosphamide on tumor growth inhibition revealed that increased HIF-1α expression significantly predictive of therapeutic resistance [10]. Here, HIF1A is linked to neoplasm.